Companies / Ocular Therapeutix, Inc
Ocular Therapeutix, Inc
Nasdaq: OCULCIK 1393434BEDFORD, MA
Financials · FY2025
Ownership
219.6M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 2.88% | 6,315,211 |
| 10%+ / strategic | 4.20% | 9,234,132 |
| Institutions | 78.73% | 172,894,163 |
| Public float | 14.19% | 31,172,362 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 17
View all →| Insider | % of shares | Shares |
|---|---|---|
Dugel PravinSee Remarks · Director | 1.50% | 3,291,981 |
Notman DonaldChief Operating Officer | 0.17% | 366,356 |
Nayak SanjayChief Strategy Officer | 0.15% | 328,795 |
Heier Jeffrey S.Chief Scientific Officer | 0.15% | 320,350 |
Waheed NadiaChief Medical Officer | 0.14% | 300,079 |
Kaiser PeterChief Development Officer | 0.12% | 266,141 |
Lindstrom Richard L MdDirector | 0.12% | 260,933 |
Saroj NamrataChief Business Officer | 0.12% | 254,620 |
Meyers Steve LawrenceChief Commercial Officer | 0.10% | 217,628 |
Anderman ToddChief Legal Officer | 0.07% | 152,468 |
Institutional holders 255
View all →| Holder | Value | % of shares |
|---|---|---|
| $385.88M | 14.47% | |
| $190.28M | 8.82% | |
| $140.52M | 5.27% | |
| $130.84M | 4.91% | |
| $97.97M | 3.67% | |
| $88.81M | 3.33% | |
| $69.69M | 2.61% | |
| $56.15M | 2.11% | |
| $51.39M | 2.38% | |
| $50.13M | 1.88% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Exit | — | $-56.15M | -4.6M -100.00% | — | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $37.06M | +3.8M +24.19% | 19,376,555 8.82% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Trim | — | $-35.26M | -4.2M -98.38% | 68,500 0.03% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | — | $-26.88M | -3.2M -98.94% | 34,006 0.02% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | — | $16.34M | +1.9M +252.64% | 2,692,622 1.23% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $12.28M | +1.4M +380.72% | 1,830,159 0.83% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $10.18M | +1.0M +24.71% | 5,233,282 2.38% of shares | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Trim | — | $-7.92M | -935K -81.07% | 218,478 0.10% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G/A | — |
| Venrock Healthcare Capital Partners III, L.P. | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G | — |
| Deep Track Capital, LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| OCUL | — | 67576A100 |